Black Rose Indus

- The company has not indicated any immediate plans to raise funds currently. - Mentioned that once technology and processes for new projects are finalized, they will consider fundraising options at the appropriate time. - Specifically, for the polyacrylamide solid plant, an investment of ₹60 to ₹100 crores is anticipated depending on the technology chosen. - The mode of raising this capital (debt/equity) will be decided when implementation starts. - Management emphasized no current need to raise funds or dilute equity. - Any future fundraising will be aligned with project requirements and finalized plans. In summary, no current fundraising is underway, but future fundraising may occur based on technology finalization and project commencement.

- Black Rose Industries is planning a polyacrylamide solid plant requiring an investment between ₹60 to ₹100 crore, depending on the technology chosen (domestic or imported). - The company is in advanced discussions for a specialty chemicals project at the Jhagadia site in collaboration with a Japanese principal. - Talks are underway for two toll manufacturing projects related to acrylamide chemistry with companies from Europe and the US. - The company is also seeking to acquire about 20 acres of new land for future projects and expansion requirements. - Fund-raising for these investments will be considered at the appropriate time after finalizing the technology and project details. - Current capital expenditure on existing capacity setups (like NMA and acrylamide solid) has been very low, benefiting from low CapEx structures.

- Acrylamide solid export volumes expected to increase this quarter due to new customer acquisition and better product acceptance despite global market disruptions (Page 17). - Polyacrylamide liquid sales affected by subdued demand in Morbi tile industry but new R&D efforts on improved binders and dispersants aim to boost revenue and product mix (Page 5). - NMA (N-Methyl Acetoacetamide) commercial sales started with a large customer, expected to raise revenue and profit substantially (Page 5). - Distribution business anticipates substantial volume and revenue growth supported by stable domestic demand, improved supply from principals, and expected export volume pick-up after US demand revival (Page 4). - Manufacturing volumes largely flat quarter-to-quarter, but 9 months show slight growth with expectation to surpass previous fiscal year volumes (Page 15). - At full capacity and current market conditions, manufacturing revenue potential estimated between ₹300 to ₹400 crores (Page 14). - Overall focus remains on maximizing sales, revenue, and profitability aligned with competitive pricing and cost efficiencies (Pages 14-17).

- Manufacturing revenue at full capacity for current four products is estimated between ₹300-400 crores, though market prices are variable (Page 14). - Company aims to maximize sales and revenue rather than focus solely on capacity utilization (Page 14). - Export volumes for acrylamide solid are expected to increase in the current quarter by reaching new customers, compensating for some global market disruptions (Page 17). - Distribution volumes and revenues are anticipated to increase substantially due to stable domestic demand, improved supplies, and renewed export demand, particularly from the US (Page 4). - EBITDA margins have improved for the fifth consecutive quarter, indicating ongoing profitability improvement (Page 3). - The focus remains on prudent raw material management and R&D to enhance product mix and margins (Pages 4,5). - Overall, the company expects to beat the previous financial year's manufacturing volumes by year-end, projecting growth in earnings and profitability (Page 15).

- The transcript does not provide explicit details on the current or expected order book and pending orders for Black Rose Industries Limited. - There are concerns raised by participant Dhaval Shah about the slow execution and prolonged negotiations (e.g., toll management contracts ongoing for 6-9 months). - No specific figures or definitive timelines are shared regarding order backlog or pending orders during the Q3 FY24 webinar. - The company emphasizes focus on maximizing sales and expanding exports, especially for acrylamide solid, by reaching newer customers. - Manufacturing volumes are described as flattish to slightly higher compared to the previous year, indicating stable order flow but no quantified order book details. - Management refrains from sharing sensitive capacity or order specifics to avoid disclosing information to competitors.